Generics - Rest of the World, Markets & Marketing

Filter

Popular Filters

Increased use of generic drugs in South Africa could save health sector 400 million rand

Increased use of generic drugs in South Africa could save health sector 400 million rand

02-10-2013

In South Africa, a switch of 5% of the volume of branded medicines to a generic equivalent could save…

FinancialGenericsHealthcareMarkets & MarketingRest of the WorldSouth Africa

Hikma sets up JV for entering Ethiopian pharma market

Hikma sets up JV for entering Ethiopian pharma market

18-09-2013

Jordon-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has signed a 50:50 joint…

GenericsHikma PharmaceuticalsMarkets & MarketingMergers & AcquisitionsMIDROC PharmaceuticalsRest of the World

Greater generic drug penetration could reduce private health care cost in South Africa

18-07-2013

Recently, two of the larger hospital groups in South Africa, Netcare and Mediclinic, called for the Competition…

FinancialGenericsHealthcareMarkets & MarketingRest of the World

Less than 30% of drugs in Nigeria made locally

15-07-2013

Last week, the Director General, of Nigeria's National Agency for Foods, Drugs Administration and Control,…

GenericsMarkets & MarketingPharmaceuticalProductionRest of the World

Brazilian pharma exports to GCC up 73% to reach over $7.4 million in 2012

13-05-2013

Brazil exported $7.48 million worth of pharmaceutical products to the Gulf Cooperation Council (GCC)…

GenericsMarkets & MarketingPharmaceuticalRest of the WorldSouth America

Mylan delivers "one pill once a day" ARV in South Africa; Cipla Debuts first Enbrel biosimilar

17-04-2013

USA-based generic drugmaker Mylan (Nasdaq: MYL) says that it has delivered, through its South African-based…

AmgenAnti-Arthritics/RheumaticsAnti-viralsAsia-PacificBiotechnologyCiplaEnbrelEtaceptGenericsMarkets & MarketingMylan LaboratoriesPfizerRest of the World

Experts to examine opportunities in growing African pharmaceutical market

12-03-2013

"At a time when growth in traditional pharmaceutical markets is stalling, strong macroeconomic fundamentals…

GenericsMarkets & MarketingPharmaceuticalRegulationRest of the World

Anti-infective market in sub-Saharan Africa set to reach $377 million in 2018

05-03-2013

The high incidence of infectious diseases in sub-Saharan Africa is expected to sustain the demand for…

Antibiotics and Infectious diseasesGenericsMarkets & MarketingPharmaceuticalRest of the World

Mylan debuts HIV/AIDS drug portfolio in South Africa

24-02-2013

US generics company Mylan (Nasdaq: MYL) says that its subsidiary in South Africa has launched a comprehensive…

Anti-viralsGenericsMarkets & MarketingMylan LaboratoriesRest of the World

South African pharma market set to grow to $7 billion in 2018

19-02-2013

South Africa's pharmaceutical market is one of the most attractive markets in Africa. Some of the main…

GenericsMarkets & MarketingPharmaceuticalRegulationRest of the World

Impax in deal with Perrigo; Cipla eyes South Africa acquisition

22-11-2012

Impax Laboratories (Nasdaq: IPXL) said yesterday that it plans to collaborate with fellow US drugmaker…

CiplaCipla MedproGenericsImpax LaboratoriesMarkets & MarketingMergers & AcquisitionsNorth AmericaPerrigoResearchRest of the World

Saudi Arabia aims to improve national health care with patent and drug approval changes

11-11-2012

Saudi Arabia is taking back control of its health care industry, states a new report by the business…

GenericsHealthcareMarkets & MarketingPatentsPharmaceuticalRegulationRest of the World

Consumer groups call for fixed-dose HIV drugs in South African tenders

16-08-2012

Consumer groups Treatment Action Campaign and Medecins sans Frontiers have issued a call for the inclusion…

Anti-viralsGenericsHealthcareMarkets & MarketingPharmaceuticalPricingRest of the World

South Africa Pharma industry risk review

09-08-2012

The South African office of Coface, an international credit insurer, released its latest industry risk…

GenericsMarkets & MarketingPharmaceuticalProductionRest of the World

Tanzania aims to double domestic drug production

18-06-2012

Local pharma manufacturers in Tanzania have targeted increasing production capacity by 50% by 2015 hoping…

FinancialGenericsMarkets & MarketingPharmaceuticalRest of the World

Tanzanian drugmaker to start producing ARVs in August

23-05-2012

Tanzania Pharmaceutical Industries (TPI) was due to start productions earlier this year, but finalization…

Anti-viralsGenericsMarkets & MarketingPharmaceuticalRest of the WorldTanzania Pharma Industries

Sandoz links with Cinpharm for generics in Sub-Saharan Africa

24-04-2012

Sandoz, the generics business of Swiss drug major Novartis (NOVN: VX), said yesterday that its German…

CinpharmGenericsMarkets & MarketingNovartisRest of the WorldSandoz

Ranbaxy opens new plant in Morocco

12-03-2012

Ranbaxy Morocco, a unit of India's largest drugmaker Ranbaxy Laboratories (AB: BO), which is majority…

Daiichi SankyoGenericsMarkets & MarketingRanbaxy LaboratoriesRest of the World

New pharma plant in Tanzania to produce ARVs

07-03-2012

Tanzania will start the first domestic commercial production of antiretroviral (ARV) drugs in the next…

Anti-viralsGenericsMarkets & MarketingRest of the World

New low cost HIV drug to be made by Ugandan company

09-02-2012

Starting as early as next month, Uganda will produce a new low cost and more effective life saving HIV/AIDS…

Anti-viralsGenericsMarkets & MarketingRest of the WorldTenofovir Disoproxil Fumarate

Kenya court set to deliver ruling on anti-counterfeit law

27-01-2012

After almost three years of waiting since three petitioners living with HIV filed a constitutional petition…

GenericsLegalMarkets & MarketingPharmaceuticalRest of the World

Significant advances in biosimilar medicines claimed for Iran

23-01-2012

Iran is making significant advances in medicine production, especially in the fields of biosimilar and…

BiotechnologyGenericsMarkets & MarketingRest of the World

Fake drugs dashing hopes of controlling malaria in Africa

17-01-2012

The emergence of fake and poor quality anti-malarial drugs could dash hopes of controlling malaria in…

GenericsMarkets & MarketingPharmaceuticalRest of the WorldTropical diseases

Natco in biogenerics in deal with Mabxience; plans generic launches in South Africa

06-11-2011

Hyderabad, India-based generic drugmaker Natco Pharma (524816: BY) has entered into an exclusive agreement…

Asia-PacificbevacizumabBiotechnologyetanerceptGenericsLicensingMabxienceMarkets & MarketingNatco PharmaRest of the Worldrituximabtrastuzumab

Back to top